Published in Health Econ Rev on November 14, 2014
Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2009) 18.03
Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke (1993) 2.44
Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study. Eur Heart J (2012) 2.16
Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes. J Am Coll Cardiol (2007) 2.08
Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke (2000) 1.86
Comparison of long-term mortality across the spectrum of acute coronary syndromes. Am Heart J (2006) 1.21
Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand. J Pharm Biomed Anal (2004) 1.19
Mortality following non-ST elevation acute coronary syndrome: 4 years follow-up of the PRAIS UK Registry (Prospective Registry of Acute Ischaemic Syndromes in the UK). Eur Heart J (2004) 0.95
Thai Registry in Acute Coronary Syndrome (TRACS)--an extension of Thai Acute Coronary Syndrome registry (TACS) group: lower in-hospital but still high mortality at one-year. J Med Assoc Thai (2012) 0.91
Demographic, management practices and in-hospital outcomes of Thai Acute Coronary Syndrome Registry (TACSR): the difference from the Western world. J Med Assoc Thai (2007) 0.85
A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet (2011) 5.61
Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med (2014) 2.90
A risk score for predicting incident diabetes in the Thai population. Diabetes Care (2006) 2.21
Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol (2005) 1.76
Risk indicators of periodontal disease in older Thai adults. J Periodontol (2005) 1.63
Changes in prevalence, awareness, treatment and control of hypertension in Thai population, 2004-2009: Thai National Health Examination Survey III-IV. J Hypertens (2012) 1.39
Arterial stiffness contributes to coronary artery disease risk prediction beyond the traditional risk score (RAMA-EGAT score). Heart Asia (2012) 1.30
Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol (2014) 1.20
Cohort profile: the electricity generating authority of Thailand study. Int J Epidemiol (2011) 1.17
Abdominal obesity and coronary heart disease in Thai men. Obesity (Silver Spring) (2007) 0.97
Serum uric acid levels in relation to bone-related phenotypes in men and women. J Clin Densitom (2012) 0.96
Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand. Thromb Res (2013) 0.92
Thai Registry in Acute Coronary Syndrome (TRACS)--an extension of Thai Acute Coronary Syndrome registry (TACS) group: lower in-hospital but still high mortality at one-year. J Med Assoc Thai (2012) 0.91
The impact of different GFR estimating equations on the prevalence of CKD and risk groups in a Southeast Asian cohort using the new KDIGO guidelines. BMC Nephrol (2012) 0.90
Long-term effects of socioeconomic status on incident hypertension and progression of blood pressure. J Hypertens (2012) 0.89
A reduced serum level of total osteocalcin in men predicts the development of diabetes in a long-term follow-up cohort. Clin Endocrinol (Oxf) (2012) 0.89
A comparison of components of two definitions of the metabolic syndrome related to cardiovascular disease and all-cause mortality in a cohort study in Thailand. Diabetes Care (2007) 0.87
Safety of herbal products in Thailand: an analysis of reports in the thai health product vigilance center database from 2000 to 2008. Drug Saf (2011) 0.86
Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway. Asian Pac J Allergy Immunol (2009) 0.86
Associations of lifestyle factors, disease history and awareness with health-related quality of life in a Thai population. PLoS One (2012) 0.85
Lipid treatment assessment project II in Thailand (LTAP-II Thailand). J Med Assoc Thai (2008) 0.84
Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspective. Asia Pac J Clin Oncol (2012) 0.83
Prevalence of dyslipidemia and goal attainment after initiating lipid-modifying therapy: a Thai multicenter study. Angiology (2012) 0.82
A longitudinal causal relationship among cardiovascular risk factors in the employees of the government savings bank. J Med Assoc Thai (2002) 0.81
Causal relationship between body mass index and fetuin-A level in the asian population: a bidirectional Mendelian randomization study. Clin Endocrinol (Oxf) (2013) 0.81
The Effect of Egg Consumption in Hyperlipidemic Subjects during Treatment with Lipid-Lowering Drugs. J Lipids (2012) 0.81
The risk factors of low birth weight infants in the northern part of Thailand. J Med Assoc Thai (2012) 0.80
Atorvastatin affects TLR4 clustering via lipid raft modulation. Int Immunopharmacol (2010) 0.80
Causal inference of the effect of adiposity on bone mineral density in adults. Clin Endocrinol (Oxf) (2013) 0.80
Handling time in economic evaluation studies. J Med Assoc Thai (2014) 0.79
Characterization of hypersensitivity reactions reported among Andrographis paniculata users in Thailand using Health Product Vigilance Center (HPVC) database. BMC Complement Altern Med (2014) 0.79
Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer. Asia Pac J Clin Oncol (2011) 0.79
Comparative study of two automated high-sensitivity C-reactive protein methods in a large population. Clin Biochem (2005) 0.79
Intrauterine nutrition and carotid intimal media thickness in young Thai adults. Asia Pac J Clin Nutr (2012) 0.78
Prevalence and factors associated with metabolic syndrome among a group of Thai working population: a cross sectional study. J Med Assoc Thai (2013) 0.78
Prognostic effect of mean platelet volume in patients with coronary artery disease. A systematic review and meta-analysis. Thromb Haemost (2015) 0.77
Costs of payment in Thai acute coronary syndrome patients. J Med Assoc Thai (2007) 0.77
Association of statin therapy with ventricular arrhythmias among patients with acute coronary syndrome. Heart Asia (2013) 0.77
Validity of the Thai EQ-5D in an occupational population in Thailand. Qual Life Res (2012) 0.77
Combination therapy in hypertension: an Asia-Pacific consensus viewpoint. Curr Med Res Opin (2015) 0.77
The Association of vitamin D status and fasting glucose according to body fat mass in young healthy Thais. BMC Endocr Disord (2013) 0.76
Association between serum homocysteine, folate and B12 concentration with coronary artery disease in Thai patients. J Med Assoc Thai (2004) 0.75
Hypertension and elevated heart rate: focus on the Asia Pacific region. J Hypertens (2016) 0.75
OS 18-04 HYPERTENSION AS A PREDICTOR OF PATTERN OF LV HYPERTROPHY AND GEOMETRIC REMODELING IN ELDERLY: HAPPY MODEL STUDY. J Hypertens (2016) 0.75
Prevalence of Brugada ECG Pattern in Thailand From a Population-Based Cohort Study. J Am Coll Cardiol (2017) 0.75
Cost-benefit analysis of an intensive adverse product reactions monitoring program of inpatients in Thailand. Southeast Asian J Trop Med Public Health (2006) 0.75
Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand. Int J Clin Pharm (2011) 0.75
OS 18-04 HYPERTENSION AS A PREDICTOR OF PATTERN OF LV HYPERTROPHY AND GEOMETRIC REMODELING IN ELDERLY: HAPPY MODEL STUDY. J Hypertens (2016) 0.75
Comparison of two homogeneous HDL cholesterol methods in a large population study. Clin Biochem (2004) 0.75